This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
Blood
Download PDF
Print
Journal Information
Journal Title
Blood
Publisher
ISSN
0006-4971
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences
Classification History
Year
A+
A
B
C
2026
✓
✓
2025
✓
✓
2024
✓
✓
2023
✓
✓
2021/2022
✓
✓
2020
✓
✓
2019
✓
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Adult hematopoietic stem cells activate a normally fetal-restricted program to functionally expand ex vivo
Kyomi J Igarashi, Matthew Nicholls, Leonid Olender et al.
2026-11-4
DOI:
10.1182/blood.2025030268
USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in <i>KMT2Ar</i> acute leukemia
Sarah Bröchtel, Constanze Schneider, Marius Müller et al.
2026-10-29
Vol. 148
Issue 18
Pages 2251-2263
DOI:
10.1182/blood.2025031845
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma
Teresa Poggio, Linda Gräßel, Geoffroy Andrieux et al.
2026-10-29
Vol. 148
Issue 18
Pages 2264-2277
DOI:
10.1182/blood.2026033240
ITP: a new CAR for an old road
John W. Semple, Rick Kapur
2026-10-29
Vol. 148
Issue 18
Pages 2217-2219
DOI:
10.1182/blood.2026035830
A TAG team for achieving deep remissions in BPDCN
Peter Carlsgaard, Stephen S. Chung
2026-10-29
Vol. 148
Issue 18
Pages 2209-2210
DOI:
10.1182/blood.2026035436
CD4+ T cells facilitate immunotherapy in ALK+ ALCL
Richard Moriggl
2026-10-29
Vol. 148
Issue 18
Pages 2214-2215
DOI:
10.1182/blood.2026035434
MEIS1 guardian USP22 fuels transcription in <i>KMT2A</i> <i>r</i> leukemia
Daniela V. Wenge
2026-10-29
Vol. 148
Issue 18
Pages 2212-2213
DOI:
10.1182/blood.2026035512
Tagraxofusp, azacitidine, and venetoclax for blastic plasmacytoid dendritic cell neoplasm
Andrew A. Lane, Marlise R. Luskin, Julia Keating et al.
2026-10-29
Vol. 148
Issue 18
Pages 2229-2238
DOI:
10.1182/blood.2026033906
CAR transgenic T-cell lymphoproliferative neoplasm: malignant transformation of cellular immunotherapy
Francis Baumgartner, Michael Dickinson, Piers Blombery
2026-10-29
Vol. 148
Issue 18
Pages 2221-2228
DOI:
10.1182/blood.2026033477
BCMA-directed CAR T-cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia
Jinhui Shu, Min Xu, Peiru Li et al.
2026-10-29
Vol. 148
Issue 18
Pages 2306-2312
DOI:
10.1182/blood.2026035047
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 31, 2026 13:02